nav-left cat-right
cat-right

Direvo completes laboratory scale development of l...

Cologne, Germany, November 19, 2013. Direvo Industrial Biotechnology GmbH (Direvo) announces the successful completion of laboratory scale development of a fermentation process for low cost production of L-lactic acid, a part of its BluCon® technology platform. The technology platform enables one-step conversion of nonfood biomass to valuable chemicals, for example lactic acid. Direvo´s CEO Jorg Riesmeier stated, “Our...

FDA says new cholesterol drugs may not need outcom...

Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower “bad” cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug Administration said on Thursday. The statement eased industry concerns that the agency would require more onerous “outcome” studies before approving the drugs,...

Trio of New York biomedical institutions join forc...

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College announced today that they have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) and have partnered with Takeda Pharmaceutical Company, Ltd. This new, groundbreaking institute, designed to expedite early-stage drug discovery into innovative treatments and therapies for patients, was...

Advanced research instrumentation – HEPA-fil...

HypoxyLab™ provides a physiologically reproducible, contamination-free, low oxygen/hypoxia environment to create optimal conditions for life science and clinical medicine research Abingdon, UK, 12th November 2013. – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ – the industry’s first...

Pneumonia and Diarrhea continue to be the leading ...

New Progress Report finds that India continues to have low coverage levels for prevention and treatment interventions for these easily preventable diseases New Delhi, 12 November, 2013 – The Pneumonia and Diarrhea Progress Report 2013 published by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health today highlights that India continues to have the largest pneumonia and diarrheal...

Infectious Diseases: Clinical Tests On Innovative ...

Vienna, Austria, November 7, 2013 – A vaccine against the dreaded Chikungunya fever, developed by Vienna-based biotech company Themis Bioscience, is now undergoing clinical testing for the first time. The vaccine, which is based on a standard anti-measles vaccine, offers a genuine opportunity to halt the spread of the disease, which was originally restricted to tropical countries. Due to a lack of vaccinations, the...
Page 20 of 63« First...10...1819202122...304050...Last »